HLN Haleon plc stock chart & analysis
Conviction 69Consumer DiscretionaryScan · Fri, Nov 6, 2026Haleon plc (HLN) closed at $9.14 (-0.11%) on Nov 6, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 44, RS Rating 41, -19.0% from its 52-week high, -9.6% year to date. Sector: Consumer Discretionary · Drug Manufacturers - Specialty & Generic.
HLN technical analysis
Trend
HLN is in a downtrend: price is below the 50-day, which is below the 200-day moving average. It closed 3.1% below the 50-day ($9.43) and 6.2% below the 200-day ($9.74). ADX(14) at 30 points to a strong, established trend. It meets 1 of 8 trend-template criteria.
Momentum
RSI(14) is 44, in the bearish half of its range. MACD crossed below its signal line 6 sessions ago. Its RS Rating of 41 puts its weighted 12-month performance ahead of about 41% of the US market.
Volume and volatility
Volume on the latest session ran 0.4× its 20-day average. It trades about $211.5M a day on average. ATR(14) is $0.2791, 3.1% of price — its typical daily range.
Key levels
The chart pattern's support is $8.53 and its resistance $9.91. The 52-week range is $8.38 to $11.28; price is 19.0% below the high and 9.0% above the low. The VWAP anchored at the 52-week high is $9.54, above price.
Performance
HLN returned +5.5% (1 week), -1.4% (1 month), -8.0% (3 months), +0.3% (6 months), -1.9% (1 year), -9.6% (year to date).
About Haleon plc
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Drug Manufacturers - Specialty & Generic · Listed 2022 · 24,524 employees
Signal lifecycle
How this symbol has moved through the lanes across 60 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.
- Setting upOct 12 – Oct 142 scans
- Breaking out nowOct 151 scan
- Broke outOct 16 – Oct 192 scans
Congress activity
Disclosed STOCK Act trades in HLN · 6 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Valerie Hoyle house · D · OR · traded 2025-09-23 | Sell | $1K–$15K | 2025-09-23 | 2025-10-10 | |
Valerie Hoyle house · D · OR · traded 2024-10-29 | Buy | $1K–$15K | 2024-10-29 | 2025-09-12 | |
 Lisa McClain house · R · MI · traded 2025-07-10 | Sell | $1K–$15K | 2025-07-10 | 2025-08-13 | |
Lisa McClain house · R · MI · traded 2025-06-24 | Buy | $1K–$15K | 2025-06-24 | 2025-08-13 | |
 Josh Gottheimer house · D · NJ · traded 2025-04-09 | Sell | $1K–$15K | 2025-04-09 | 2025-05-14 | |
Josh Gottheimer house · NJ · traded 2024-05-20 | Buy | $1K–$15K | 2024-05-20 | 2024-06-05 |
SEC filings
EDGAR filings in HLN · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.